サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562326

欧州の慢性疼痛向け脊髄刺激装置：2030年までの市場予測 - 地域分析 - 製品タイプ、用途、エンドユーザー別

Europe Spinal Cord Stimulation Device for Chronic Pain Market Forecast to 2030 - Regional Analysis - by Product Type, Application, and End User

出版日
ページ情報
英文 157 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
欧州の慢性疼痛向け脊髄刺激装置：2030年までの市場予測 - 地域分析 - 製品タイプ、用途、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 157 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

慢性疼痛向け脊髄刺激装置市場は、2022年に7億9,987万米ドルと評価され、2030年には14億1,201万米ドルに達すると予測され、2022年から2030年までのCAGRは7.4%と推定されます。

脊髄損傷に効果的な治療を提供するリハビリと専門センターが慢性疼痛向け脊髄刺激装置市場を後押し

NIHの報告書によると、脊髄損傷の専門治療センターは、患者のケアと神経学的回復を改善する目的で、英国で最初に設立されました。SCI三次医療センターは、急性SCIを患う患者の臨床転帰と神経学的回復を改善するために開発されました。さらに、ドイツのハイデルベルク大学病院の脊髄損傷センターは、脊髄損傷の治療と研究に特化した唯一の学術センターです。ハイデルベルク大学病院のスタッフは～145人で、年間～1,500人の急性または慢性の脊髄損傷患者に治療を行っており、そのうち1,000人は外来治療を受けています。

脊髄刺激装置はリハビリテーションセンターで非常に多く採用されています。これらの機器に基づく治療法は、患者を身体的・心理的にサポートし、短期間で神経学的回復と全身の健康を最大化します。ベルリンにあるウォーク・アゲイン・センターは、神経疾患を治療するリハビリセンターの一例です。このリハビリセンターは、脊髄損傷の治療に医学と技術の両方を取り入れています。構造的、神経的な神経可塑性を含む革新的な医療処置を用い、医師が脳の損傷に苦しむ患者に治療を提供しています。したがって、先進的なリハビリセンターと専門センターは、欧州の慢性疼痛向け脊髄刺激装置市場に成長機会を提供しています。

欧州の慢性疼痛向け脊髄刺激装置市場概要

欧州の慢性疼痛向け脊髄刺激装置市場は、地域別にドイツ、フランス、イタリア、スペイン、英国、スイス、オランダ、スウェーデン、その他欧州に区分されます。ヘルスケア請求の増加と関連コスト、行政取引の増加、サプライチェーン追跡における慢性疼痛向け脊髄刺激装置プラットフォームは、市場成長を推進する顕著な要因の一つです。例えば、イタリアでは、病院での脊髄治療はイタリア国民保健制度（NHS）を通じて保険で完全にカバーされています。そのため、イタリア国民の間では、脊髄損傷に有効な治療法があるという認識が高いです。したがって、脊髄損傷に対する適切な医療保険規定があることは、イタリアの病院や専門センターにおける脊髄刺激装置の需要が高いことを意味します。

欧州の慢性疼痛向け脊髄刺激装置市場の収益と2030年までの予測（金額）

慢性疼痛向け脊髄刺激装置の欧州市場セグメンテーション

慢性疼痛向け脊髄刺激装置市場は、製品タイプ、用途、エンドユーザー、国によって区分されます。

製品タイプに基づき、慢性疼痛向け脊髄刺激装置市場は充電式と非充電式に二分されます。2022年には充電式セグメントがより大きなシェアを占めています。

用途別では、慢性疼痛向け脊髄刺激装置市場は、故障性腰部症候群、複合性局所疼痛症候群、変性ディスク疾患、その他に区分されます。複合性局所疼痛症候群のセグメントが2022年に最も大きなシェアを占めています。

エンドユーザー別では、慢性疼痛向け脊髄刺激装置市場は病院、外来手術センター（ASCS）、その他に区分されます。病院セグメントが2022年に最大のシェアを占めました。

国別では、慢性疼痛向け脊髄刺激装置市場はドイツ、フランス、英国、スペイン、イタリア、スイス、スウェーデン、ポーランド、ベルギー、スロバキア、チェコ共和国、ギリシャ、アイルランド、オランダ、その他欧州に分類されます。ドイツが2022年の慢性疼痛向け脊髄刺激装置市場を独占しました。

Boston Scientific Corp、Abbott Laboratories、Medtronic Plc、Biotronik SE &Co KG、Nevro Corp、Cirtec Medical Corp、Synapse Biomedical Incは、欧州の慢性疼痛向け脊髄刺激装置市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 欧州の慢性疼痛向け脊髄刺激装置市場：要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 欧州の慢性疼痛向け脊髄刺激装置市場：市場情勢

  • 企業シェア分析
  • 価格分析

第5章 慢性疼痛向け脊髄刺激装置の欧州市場

  • 市場促進要因
    • 脊髄損傷の増加
    • EUにおける革新的治療の利用可能性
  • 市場抑制要因
    • 製品リコール
  • 市場機会
    • 脊髄損傷に効果的な治療を提供するリハビリテーションおよび専門センター
  • 今後の動向
    • 再生医療と革新的なインプラントを用いた治療アプローチ
  • 影響分析

第6章 慢性疼痛向け脊髄刺激装置市場：欧州分析

  • 慢性疼痛向け脊髄刺激装置の欧州市場収益と分析

第7章 欧州の慢性疼痛向け脊髄刺激装置市場の収益と2030年までの予測：製品タイプ別

  • 市場収益シェア、2022年および2030年
  • 充電式
  • 非充電式

第8章 欧州の慢性疼痛向け脊髄刺激装置市場の収益と2030年までの予測：用途別

  • 腰痛症
  • 複合性局所疼痛症候群
  • 変性椎間板疾患
  • その他

第9章 欧州の慢性疼痛向け脊髄刺激装置市場の収益と2030年までの予測：エンドユーザー別

  • 市場収益シェア、2022年および2030年
  • 病院
  • 外来手術センター（ASCs）
  • その他

第10章 欧州の慢性疼痛向け脊髄刺激装置市場の収益と2030年までの予測：国別分析

  • 欧州
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
  • スイス
  • オランダ
  • スウェーデン
  • ベルギー
  • ポーランド
  • スロバキア
  • チェコ共和国
  • ギリシャ
  • アイルランド
  • その他欧州

第11章 業界情勢

  • 市場における各社の成長戦略（%）
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Boston Scientific Corp
  • Abbott Laboratories
  • Medtronic Plc
  • Biotronik SE & Co KG
  • Nevro Corp
  • Cirtec Medical Corp
  • Synapse Biomedical Inc

第13章 付録

図表

List Of Tables

  • Table 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation
  • Table 2. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 3. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 4. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 5. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 6. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 7. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 8. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 9. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 10. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 11. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 12. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 13. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 15. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 16. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 17. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 18. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 19. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 20. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 21. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 22. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 23. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 24. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 25. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 27. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 28. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 29. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 30. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 33. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 34. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 35. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 36. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 37. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 38. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 39. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 40. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 41. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 42. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 43. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 44. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Product Type
  • Table 45. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 46. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 47. Organic Developments Done By Companies
  • Table 48. Inorganic Developments Done By Companies
  • Table 49. Glossary of Terms

List Of Figures

  • Figure 1. Europe Spinal Cord Stimulation Device for Chronic Pain Market, by Country
  • Figure 2. Key Insights
  • Figure 3. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Company Share Analysis
  • Figure 4. Europe Spinal Cord Stimulation Device Market for Chronic Pain: Pricing Analysis
  • Figure 5. Europe Spinal Cord Stimulation Device for Chronic Pain Market- Key Industry Dynamics
  • Figure 6. Europe Spinal Cord Stimulation Device for Chronic Pain Market: Impact Analysis of Drivers and Restraints
  • Figure 7. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue Forecast and Analysis - 2020-2030
  • Figure 8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • Figure 9. Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
  • Figure 12. Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
  • Figure 17. Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Europe Spinal Cord Stimulation Device for Chronic Pain Market, Country 2022 ($Mn)
  • Figure 21. Europe: Spinal Cord Stimulation Device for Chronic Pain Market, By Key Countries, 2022 And 2030 (%)
  • Figure 22. Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 23. France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 24. Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 25. Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 26. United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 28. Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 32. Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 34. Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Growth Strategies Done by the Companies in the Market (%)
目次
Product Code: BMIRE00030432

The spinal cord stimulation device for chronic pain market was valued at US$ 799.87 million in 2022 and is expected to reach US$ 1,412.01 million by 2030; it is estimated to register at a CAGR of 7.4% from 2022 to 2030.

Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries Fuels Spinal Cord Stimulation Device for Chronic Pain Market

According to a report by the NIH, specialized centers of care for SCI were first established in England with an objective to improve the care and neurological recovery of patients. SCI tertiary care centers are developed to improve clinical outcomes and neurological recovery among patients suffering from acute SCIs. Additionally, the Spinal Cord Injury Center at Heidelberg University Hospital in Germany is the only academic center dedicated to the treatment and research of SCIs. The staff at Heidelberg University Hospital, including ~145 staff members, provides treatment to ~1,500 patients suffering from acute or chronic spinal cord injuries annually, among which 1,000 receive outpatient care.

Spinal cord stimulation devices are highly adopted in rehabilitation centers. A treatment method based on these devices supports patients physically and psychologically to maximize their neurological recovery and general health in a short time. The Walk Again Center based in Berlin is one such example of a rehabilitation center to treat neurological conditions. This rehab center employs both medicine and technology to treat SCIs. It uses innovative medical procedures, including structural and neural neuroplasticity, where doctors provide therapy to patients suffering from brain damage. Therefore, advanced rehab centers and specialized centers provide growth opportunities to the Europe spinal cord stimulation devices for chronic pain market.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Overview

Europe spinal cord stimulation device for chronic pain market by region, is segmented as Germany, France, Italy, Spain, United Kingdom, Switzerland, Netherlands, Sweden, and Rest of Europe. The rising healthcare claims and associated costs, increasing administrative transactions, and spinal cord stimulation device for chronic pain platform in supply chain tracking are among the prominent factors propelling the market growth. for instance, in Italy, spinal cord treatments in hospitals are fully covered under insurance through the Italian National Health System (NHS). Therefore, there is high awareness of effective treatments available for SCIs among the Italian population. Therefore, the availability of proper health coverage provisions for SCI signifies a high demand for spinal cord stimulation devices among hospitals and specialty centers in Italy.

Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and forecast to 2030 (US$ Million)

Europe Spinal Cord Stimulation Device for Chronic Pain Market Segmentation

The spinal cord stimulation device for chronic pain market is segmented based on product type, application, end user, and country.

Based on product type, the spinal cord stimulation device for chronic pain market is bifurcated into rechargeable and non-rechargeable. The rechargeable segment held a larger share in 2022.

In terms of application, the spinal cord stimulation device for chronic pain market is segmented into failed back syndrome, complex regional pain syndrome, degenerative disk disease, and others. The complex regional pain syndrome segment held the largest share in 2022.

By end user, the spinal cord stimulation device for chronic pain market is segmented into hospitals, ambulatory surgery centers (ASCS), and others. The hospitals segment held the largest share in 2022.

Based on country, the spinal cord stimulation device for chronic pain market is categorized into Germany, France, the UK, Spain, Italy, Switzerland, Sweden, Poland, Belgium, Slovakia, Czech Republic, Greece, Ireland, the Netherland, and the Rest of Europe. Germany dominated the spinal cord stimulation device for chronic pain market in 2022.

Boston Scientific Corp, Abbott Laboratories, Medtronic Plc, Biotronik SE & Co KG, Nevro Corp, Cirtec Medical Corp, and Synapse Biomedical Inc are some of the leading companies operating in the Europe spinal cord stimulation device for chronic pain market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Product Type
    • 1.2.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Application
    • 1.2.3 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by End User
    • 1.2.4 Europe Spinal Cord Stimulation Device for Chronic Pain Market - by Country

2. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Market Landscape

  • 4.1 Company Share Analysis
  • 4.2 Pricing Analysis

5. Europe Spinal Cord Stimulation Device for Chronic Pain Market

  • 5.1 Market Drivers
    • 5.1.1 Rising Number of Spinal Cord Injuries
    • 5.1.2 Availability of Innovative Treatments in European Union
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
  • 5.3 Market Opportunities
    • 5.3.1 Rehabilitation and Specialized Centers Providing Effective Treatment for Spinal Cord Injuries
  • 5.4 Future Trends
    • 5.4.1 Regenerative and Innovative Implant-Based Therapeutic Approaches
  • 5.5 Impact analysis

6. Spinal Cord Stimulation Device for Chronic Pain Market - Europe Analysis

  • 6.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Forecast and Analysis

7. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 - by Product Type

  • 7.1 Overview
  • 7.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Product Type, 2022 & 2030 (%)
  • 7.3 Rechargeable
    • 7.3.1 Overview
    • 7.3.2 Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Non-Rechargeable
    • 7.4.1 Overview
    • 7.4.2 Non-Rechargeable: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by Application

  • 8.1 Overview
    • 8.1.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by Application (2022 and 2030)
  • 8.2 Failed Back Syndrome
    • 8.2.1 Overview
    • 8.2.2 Failed Back Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Complex Regional Pain Syndrome
    • 8.3.1 Overview
    • 8.3.2 Complex Regional Pain Syndrome: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Degenerative Disk Disease
    • 8.4.1 Overview
    • 8.4.2 Degenerative Disk Disease: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Others
    • 8.5.1 Overview
    • 8.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecasts to 2030- by End User

  • 9.1 Overview
  • 9.2 Europe Spinal Cord Stimulation Device for Chronic Pain Market Revenue Share, by End User (2022 and 2030)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Europe Spinal Cord Stimulation Device for Chronic Pain Market- Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgery Centers (ASCs)
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgery Centers (ASCs): Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Spinal Cord Stimulation Device for Chronic Pain Market - Revenue and Forecast to 2030 -Country Analysis

  • 10.1 Europe Spinal Cord Stimulation Device for Chronic Pain Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
      • 10.1.1.1 Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Countries
      • 10.1.1.2 Germany
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Germany: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.2.3 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.2.4 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.2.5 Germany: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.3 France
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 France: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.3.3 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.3.4 France: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.3.5 France: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.4 Italy
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Italy: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.4.3 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.4.4 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.4.5 Italy: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.5 Spain
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 Spain: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.5.3 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.5.4 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.5.5 Spain: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.6 United Kingdom
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.6.3 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.6.4 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.6.5 United Kingdom: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.7 Switzerland
        • 10.1.1.7.1 Overview
        • 10.1.1.7.2 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.7.3 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.7.4 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.7.5 Switzerland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.8 Netherlands
        • 10.1.1.8.1 Overview
        • 10.1.1.8.2 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.8.3 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.8.4 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.8.5 Netherlands: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.9 Sweden
        • 10.1.1.9.1 Overview
        • 10.1.1.9.2 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.9.3 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.9.4 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.9.5 Sweden: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.10 Belgium
        • 10.1.1.10.1 Overview
        • 10.1.1.10.2 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.10.3 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.10.4 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.10.5 Belgium: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.11 Poland
        • 10.1.1.11.1 Overview
        • 10.1.1.11.2 Poland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.11.3 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.11.4 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.11.5 Poland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.12 Slovakia
        • 10.1.1.12.1 Overview
        • 10.1.1.12.2 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.12.3 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.12.4 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.12.5 Slovakia: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.13 Czech Republic
        • 10.1.1.13.1 Overview
        • 10.1.1.13.2 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.13.3 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.13.4 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.13.5 Czech Republic: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.14 Greece
        • 10.1.1.14.1 Overview
        • 10.1.1.14.2 Greece: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.14.3 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.14.4 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.14.5 Greece: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.15 Ireland
        • 10.1.1.15.1 Overview
        • 10.1.1.15.2 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.15.3 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.15.4 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.15.5 Ireland: Spinal Cord Stimulation Device for Chronic Pain Market, by End User
      • 10.1.1.16 Rest of Europe
        • 10.1.1.16.1 Overview
        • 10.1.1.16.2 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.1.16.3 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Product Type
        • 10.1.1.16.4 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by Application
        • 10.1.1.16.5 Rest of Europe: Spinal Cord Stimulation Device for Chronic Pain Market, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies Done by the Companies in the Market (%)
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Boston Scientific Corp
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Abbott Laboratories
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Medtronic Plc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Biotronik SE & Co KG
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Nevro Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Cirtec Medical Corp
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Synapse Biomedical Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms